Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Clinical trial NCT07014735 · TERMINATED

Trial details

NCT number: NCT07014735
Sponsor: Richmond Pharmacology Limited
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Type 2 Hyperglycaemia (Diabetic)QT Interval, Variation in Torsades de Pointes

Start date: 2023-04-13
Primary completion: 2026-05-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.